Under the AD-inducing condition A, the downstream effectors of RhoA – ROCK1 and ROCK2 – showed opposing outcomes in changes in their expression; ROCK1 decreased 1.3-fold (n=4) and ROCK2 increased 1.54-fold (n=4). Here, ROCK1 is linked to Alzheimer disease.